DIVITA CHARLES III 4
4 · Teladoc Health, Inc. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
DIVITA CHARLES III
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-09-10+39,160→ 195,801 total - Sale
Common Stock
2025-09-11$7.59/sh−16,787$127,435→ 179,014 total - Exercise/Conversion
Restricted Stock Units
2025-09-10−39,160→ 274,123 total→ Common Stock (39,160 underlying)
Footnotes (3)
- [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
- [F3]On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.